Citius Pharmaceuticals increases authorized shares 10x, redeems Series A Preferred for $100

Citius Pharmaceuticals, Inc.

Authorized shares increased from 26M to 260M; common shares from 16M to 250M.
Amendment approved at special meeting on June 9, 2025: 547M for, 457M against, 520K abstain.
Series A Preferred (1B votes) automatically redeemed for $100, mirrored votes cast proportionally.
Adjournment proposal became moot after amendment approval.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Citius Pharmaceuticals, Inc.: Increased authorized shares from 26,000,000 to 260,000,000 and authorized common shares from 16,000,000 to 250,000,000 (effective 2025-06-09).

Change: charter amendment
Effective: 2025-06-09

Exact text from the filing

On June 9, 2025, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to increase the authorized shares from 26,000,000 to 260,000,000 and increase the authorized common shares, par value $0.001 per share, from 16,000,000 to 250,000,000 (the “Amendment”).

View on SEC.gov

Browse all governance changes →

Citius Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-052718

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.